East Brunswick, NJ, United States of America

Reynalda De Jesus

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reynalda De Jesus. Retrieved from https://idiyas.com/inventor/reynalda-de-jesus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 15.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Reynalda De Jesus

Introduction:

Reynalda De Jesus, a talented inventor based in East Brunswick, NJ (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking patents.

Latest Patents:

De Jesus has recently patented "Oxazolidinones as TarO inhibitors," novel compounds that inhibit TarO and have the potential to treat various bacterial infections, including MRSA and MRSE. His innovative approach opens doors for new treatment options in the medical industry.

Career Highlights:

Currently employed at Merck Sharp & Dohme Corporation, De Jesus continues to drive innovation in pharmaceutical research. With four patents to his name, he exemplifies dedication and excellence in his work.

Collaborations:

In his professional journey, De Jesus has collaborated with esteemed coworkers such as Fa-Xiang Ding and Haifeng Tang. Together, they have worked on cutting-edge projects that push the boundaries of scientific discovery.

Conclusion:

Reynalda De Jesus's inventive spirit and commitment to advancing medical treatments through his patents make him a valuable asset to the field of pharmaceuticals. His contributions reflect a dedication to innovation and a passion for improving lives through science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…